We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
In the latest market close, UnitedHealth Group (UNH - Free Report) reached $565.19, with a +0.82% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.3%. Meanwhile, the Dow lost 0.35%, and the Nasdaq, a tech-heavy index, lost 0.25%.
Shares of the largest U.S. health insurer witnessed a loss of 10.34% over the previous month, trailing the performance of the Medical sector with its loss of 3.43% and the S&P 500's gain of 1.09%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company is predicted to post an EPS of $6.74, indicating a 9.42% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $101.75 billion, up 7.76% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $27.61 per share and revenue of $401.48 billion. These results would represent year-over-year changes of +9.91% and +8.03%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.02% decrease. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 20.31. For comparison, its industry has an average Forward P/E of 13.08, which means UnitedHealth Group is trading at a premium to the group.
Investors should also note that UNH has a PEG ratio of 1.65 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Medical - HMOs industry was having an average PEG ratio of 1.01.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 180, which puts it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
In the latest market close, UnitedHealth Group (UNH - Free Report) reached $565.19, with a +0.82% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.3%. Meanwhile, the Dow lost 0.35%, and the Nasdaq, a tech-heavy index, lost 0.25%.
Shares of the largest U.S. health insurer witnessed a loss of 10.34% over the previous month, trailing the performance of the Medical sector with its loss of 3.43% and the S&P 500's gain of 1.09%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company is predicted to post an EPS of $6.74, indicating a 9.42% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $101.75 billion, up 7.76% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $27.61 per share and revenue of $401.48 billion. These results would represent year-over-year changes of +9.91% and +8.03%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.02% decrease. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 20.31. For comparison, its industry has an average Forward P/E of 13.08, which means UnitedHealth Group is trading at a premium to the group.
Investors should also note that UNH has a PEG ratio of 1.65 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Medical - HMOs industry was having an average PEG ratio of 1.01.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 180, which puts it in the bottom 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.